Stay updated on Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating a newer build of the page. This update appears to be a maintenance change and does not alter study details or visible content.
    Difference
    0.1%
    Check dated 2026-05-15T05:51:51.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, indicating a backend or interface release rather than a change to the trial record content.
    Difference
    0.1%
    Check dated 2026-04-24T05:45:25.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:17:51.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Page version updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T01:15:22.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    - Updated page revision from v3.4.2 to v3.4.3. - No substantive changes to study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-03-11T18:04:13.000Z thumbnail image
  9. Check
    105 days ago
    Change Detected
    Summary
    The Study Record Dates now display 'Results Submitted' instead of 'No Results Posted', indicating that results have been submitted.
    Difference
    0.1%
    Check dated 2026-02-18T07:52:49.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page.